跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 70 条关于
“Ottimo”
全部
70
临床试验
50
药物
1
机构
2
资讯
17
去年
Former Seagen CEO Leads Ottimo Pharma's Novel Cancer Immunotherapy Development
4个月前
Lotte Biologics Expands Manufacturing Partnership with Ottimo Pharma for Biparatopic Antibody Development
8个月前
Ottimo Pharma Receives FDA Clearance for First-in-Class Dual PD-1/VEGFR2 Antibody OTP-01
去年
FDA Approves Orlynvah for Treatment of Uncomplicated UTIs in Women with Limited Options
5个月前
Frontier Medicines Appoints Former Seagen CEO David Epstein to Board as Company Advances Covalent Precision Medicine Pipeline
10个月前
Medicxi Closes €500M Fund V to Accelerate Asset-Centric Biotech Investments
10个月前
Nurix Therapeutics Strengthens Board with Former Pfizer and Seagen Executive Roger Dansey
7个月前
Alphamab Advances First PD-L1 x VEGFR2 Antibody-Drug Conjugate JSKN027 Into Clinical Trials
2年前
FDA Approves Clinical Trial for PEEK-OPTIMA Knee Implant
去年
OPTIMA Trial Explores Predictive Test for Chemotherapy in Breast Cancer Treatment
第 1 页,共 2 页
上一页
下一页